Frontiers in Microbiology (Sep 2023)

Glutamate-pantothenate pathway promotes antibiotic resistance of Edwardsiella tarda

  • Bei-bei Yan,
  • Bei-bei Yan,
  • Xue-sa Dong,
  • Jun-peng Wang,
  • Xiao-ying Li,
  • Xiao-ying Li,
  • Li An,
  • Xi-rong Wang,
  • Long-gang Zhang,
  • Qing-lei Meng,
  • Chao Wang

DOI
https://doi.org/10.3389/fmicb.2023.1264602
Journal volume & issue
Vol. 14

Abstract

Read online

Although cellular metabolic states have been shown to modulate bacterial susceptibility to antibiotics, the interaction between glutamate (Glu) and chloramphenicol (CAP) resistance remains unclear because of the specificity of antibiotics and bacteria. We found that the level of Glu was upregulated in the CAP-resistant strain of Edwardsiella tarda according to a comparative metabolomics approach based on LC–MS/MS. Furthermore, we verified that exogenous metabolites related to Glu, the tricarboxylic acid (TCA) cycle, and glutathione (GSH) metabolism could promote CAP resistance in survival assays. If GSH metabolism or the TCA cycle is inhibited by L-buthionine sulfoximine or propanedioic acid, the promotion of CAP resistance by Glu in the corresponding pathway disappears. According to metabolomic analysis, exogenous Glu could change pantothenate metabolism, affecting GSH biosynthesis and the TCA cycle. These results showed that the glutamate-pantothenate pathway could promote CAP resistance by being involved in the synthesis of GSH, entering the TCA cycle by direct deamination, or indirectly affecting the metabolism of the two pathways by pantothenate. These results extend our knowledge of the effect of Glu on antibiotic resistance and suggest that the potential effect, which may aggravate antibiotic resistance, should be considered before Glu and GSH administration in the clinic.

Keywords